Is Aspire Biopharma Holdings, Inc. (ASBP) a Buy, Sell, or Hold?
NASDAQ : ASBP
Aspire Biopharma Holdings, Inc. — Institutional Ownership
$7.73 USD
$0.67 (9.49%)
- Volume
- 39.06K
- Average Volume
- 660.57K
- Market Capitalization
- $891.83K
- P/E Ratio
- -0.92
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $35.00
- Year Low
- $0.11
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.26
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-02 | Rubenbauer Alois Ryan III | 65000.0 | 5.00% |
| 2026-05-15 | Highbridge Capital Management, LLC | 273K | 5.20% |
| 2026-05-13 | Ardsley Advisory Partners LP | - | 0.00% |
| 2026-02-12 | Ardsley Advisory Partners LP | 10.75M | 7.76% |
| 2025-05-19 | Lance Friedman | 2.21M | 4.52% |
| 2025-05-15 | Harraden Circle Investments, LLC | 150K | 0.31% |
| 2025-05-07 | Lance Friedman | 3.87M | 7.92% |
| 2025-04-23 | Lance Friedman | 4.04M | 8.25% |
| 2025-04-17 | Lance Friedman | 4.05M | 8.28% |
| 2025-04-11 | Lance Friedman | 4.18M | 8.55% |
| 2025-04-04 | Lance Friedman | 4.39M | 8.98% |
| 2025-03-28 | Lance Friedman | 4.44M | 9.08% |
| 2025-03-20 | Lance Friedman | 4.61M | 9.46% |
| 2025-03-12 | Lance Friedman | 4.8M | 9.83% |
| 2025-02-26 | Lance Friedman | 4.88M | 9.98% |
ASBP Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $158.40 | 1.49M | $236.8M | $1M | $1.38M | $237.18M |
| 2024-12-31 | $13800.00 | 689.91K | $9.52B | $3633 | $1.27M | $9.52B |
| 2023-12-31 | $13068.00 | 479.48K | $6.27B | -$ | $12384 | $6.27B |
| 2022-12-31 | $12360.00 | 898.44K | $11.1B | $497.26K | $27967 | $11.1B |
| 2021-12-31 | $11988.00 | 682.81K | $8.19B | -$ | $238.6K | $8.19B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30.90 | 1.49M | $46.19M | $5.86M | $1.5M | $41.84M |
| 2025-12-31 | $158.40 | 1.49M | $236.8M | $1M | $5.18M | $240.97M |
| 2025-09-30 | $247.20 | 1.24M | $306.07M | $1.95M | $8.62M | $312.75M |
| 2025-06-30 | $322.80 | 1.23M | $398.12M | $206.23K | $8.47M | $406.39M |
| 2025-03-31 | $699.60 | 947.25K | $662.7M | $1.35M | $6.76M | $668.12M |
| 2024-12-31 | $13800.00 | 690.04K | $9.52B | $3633 | $1.27M | $9.52B |
| 2024-09-30 | $14652.00 | 690.04K | $10.11B | $6.6M | $436.28K | $10.1B |
| 2024-06-30 | $13524.00 | 690.03K | $9.33B | -$ | $5.36M | $9.34B |
| 2024-03-31 | $13260.00 | 689.99K | $9.15B | -$ | $2M | $9.15B |
| 2023-12-31 | $13068.00 | 636.63K | $8.32B | -$ | $12384 | $8.32B |
| 2023-09-30 | $12996.00 | 636.63K | $8.27B | $280 | -$ | $8.27B |
| 2023-06-30 | $12504.00 | 793.78K | $9.93B | $125.2K | -$ | $9.93B |